Abstract
Primary and recurring breast carcinomas do not differ in the expression of proliferating cell nuclear antigen (PCNA), C-erb-2 oncoprotein, carcinoembryonic antigen and trophoblastic antigen. The content of PCNA and C-erb-2 oncoprotein is twice as high in tumors with an unfavorable prognosis and the frequency of combination of these markers is much higher comparing to tumors with a good prognosis.
MeSH terms
-
Biomarkers, Tumor*
-
Breast Neoplasms / metabolism*
-
Breast Neoplasms / pathology*
-
Carcinoembryonic Antigen / analysis*
-
Carcinoembryonic Antigen / metabolism
-
Female
-
Humans
-
Immunohistochemistry
-
Proliferating Cell Nuclear Antigen / analysis*
-
Proliferating Cell Nuclear Antigen / metabolism
-
Receptor, ErbB-2 / analysis*
-
Receptor, ErbB-2 / metabolism
-
Recurrence
Substances
-
Biomarkers, Tumor
-
Carcinoembryonic Antigen
-
Proliferating Cell Nuclear Antigen
-
Receptor, ErbB-2